Compare Merck & Co., Inc. (MRK) vs Stitch Fix Inc (SFIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Merck & Co., Inc. vs Stitch Fix Inc — how do they compare? Merck & Co., Inc. trades at $142.17 (market cap $351.28B), while Stitch Fix Inc trades at $2.75 (market cap $366.07M). The key difference: Merck & Co., Inc. is far larger — about 959.6× Stitch Fix Inc's market cap, and Merck & Co., Inc. pays a 2.39% dividend while Stitch Fix Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Merck & Co., Inc. for 98 Days and Stitch Fix Inc for 31 Days on average.
| MRK | SFIX | |
|---|---|---|
Market Cap | $351.28B | $366.07M |
Volume | 7,969,665 | 5,152,008 |
Sector | Health | Consumer Cyclical |
52-Week High | $156.43 | $5.64 |
52-Week Low | $82.49 | $2.16 |
Typical Hold Time | 98 Days | 31 Days |
Enterprise Value | $398.04B | $261.88M |
Dividend Yield | 2.39% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Merck (MRK) trades at $142.79, up 0.61% on the day, with a bearish technical signal despite beating earnings estimates in recent quarters. The company reported 2025 revenue of $65.01B and net income of $18.25B, with a high P/E ratio of 113.9 reflecting premium valuation. Recent news highlights Merck's acquisition of Terns Pharmaceuticals to bolster its oncology pipeline, while institutional investors have been increasing stakes.
The outlook is mixed: strong analyst consensus (68% buy ratings) and a $158.78 price target suggest upside, but high valuation and bearish technicals pose near-term risks. Key opportunities include pipeline expansion via M&A; risks involve integration challenges and patent pressures.
Stitch Fix (SFIX) trades at $2.73, up 2.25% on the day, but remains under pressure with a bearish technical signal and weak fundamentals. The company reported a net loss of $28.74 million in fiscal 2025, though revenue stabilized at $1.27 billion. Recent quarterly earnings have beaten expectations, but weak fiscal 2027 guidance and multiple law firm investigations have dampened sentiment. The stock is trading near the low end of analyst price targets, reflecting significant skepticism about near-term prospects.
The outlook for SFIX is challenging, with profitability remaining elusive and revenue growth stagnant. The primary opportunity lies in successful execution of its AI-driven personalization strategy to improve client engagement and margins. Key risks include intense competition, high customer acquisition costs, and the ongoing legal overhangs. Analyst consensus is cautious, with a hold rating predominant, suggesting limited upside until the company demonstrates a sustainable path to profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →About Stitch Fix Inc
Stitch Fix Inc offers personal style service for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandises with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types and price points including Women's, Petite, Maternity, Men's and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry and handbags, and sells merchandise across various range of price points.
Read more on SFIX →
